Journal article
A randomised comparison of low or high dose IFN-alpha in newly diagnosed CML patients shows no difference in major cytogenetic response rate or survival between the two groups - Results of MRC CML V and HOVON 20 trials.
- Publication status:
- Published
Actions
Authors
- Journal:
- BLOOD More from this journal
- Volume:
- 98
- Issue:
- 11
- Pages:
- 727A-727A
- Publication date:
- 2001-11-16
- ISSN:
-
0006-4971
- Pubs id:
-
pubs:95926
- UUID:
-
uuid:0f4eabe7-47ff-4a69-8734-7c7511247825
- Local pid:
-
pubs:95926
- Source identifiers:
-
95926
- Deposit date:
-
2012-12-19
Terms of use
- Copyright date:
- 2001
If you are the owner of this record, you can report an update to it here: Report update to this record